Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
146,467,184
-
Total 13F shares
-
90,103,150
-
Share change
-
+2,394,755
-
Total reported value
-
$20,611,027,939
-
Put/Call ratio
-
386%
-
Price per share
-
$228.69
-
Number of holders
-
863
-
Value change
-
+$523,118,005
-
Number of buys
-
426
-
Number of sells
-
329
Institutional Holders of RESMED INC - Common Stock (RMD) as of Q4 2024
As of 31 Dec 2024,
RESMED INC - Common Stock (RMD) was held by
863 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
90,103,150 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock, Inc., STATE STREET CORP, Bank of New York Mellon Corp, GEODE CAPITAL MANAGEMENT, LLC, MORGAN STANLEY, Invesco Ltd., NORTHERN TRUST CORP, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, and UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC.
This page lists
864
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.